Introduction
Organotin(IV) compounds are a widely studied class of metal-based anti-tumor drugs and their intensive investigation has led to the discovery of compounds with excellent in vitro anti-tumor activity, but in many cases disappointingly low in vivo potency or high in vivo toxicity [1] [2] [3] . It is well established that organotin(IV) compounds are very important in cancer chemotherapy because of their apoptosisinducing character [4, 5] . The design of improved organotin(IV) antitumor agents occupies a significant place in cancer chemotherapy, as revealed in their remarkable therapeutic potential reflected in recent research reports [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Consequently, a large number of organotin(IV) carboxylates have been investigated for their anti-tumor potential. Among organotin(IV) carboxylates, triorganotin(IV) carboxylates are quite well known for exceptionally high in vitro anti-tumor activities, e.g., triphenyltin(IV) -benzoates, -salicylates [18] , -3,6-dioxaheptanoate, -3,6,9-trioxadecanoate [19] , -4-carboxybenzo-15-crown-5, -4-carboxybenzo-18-crown-6 [19, 20] , -steroidcarboxylate [21] , -terebate [22, 23, 24] and -aminoacetates (Schiff bases) [25, 26] . From these examples, it is clear that the compounds can be developed with high in vitro antitumor activity and sufficient water solubility. The most important point remains the activity. The organotin(IV) compounds containing the diazenyl group show not only high in vitro antitumor activity, but also displayed interesting interactions with various enzymes (see below). In the present study, attempts have been made to improve the water solubility by the systematic study of various structural changes. In general, organotin(IV) compounds are dissolved in DMSO and diluted with test medium prior to the in vitro testing. The limited solubility needs further improvement in a way comparable to cisplatin which shows limited water solubility too.
In view of the remarkable activity of the triphenyltin(IV) carboxylates, triphenyltin(IV) carboxylates containing the 2-[(E)-2-(3-formyl-4-hydroxyphenyl)-1-diazenyl]benzoate and 2-[(E)-2-(4-hydroxy-5-methylphenyl)-1-diazenyl]benzoate skeletons have recently been investigated, showing encouraging cytotoxic activity across a panel of cell lines [27] . As a result of these promising cytotoxic activities, the mechanistic role of the compounds was investigated to determine the influence of the azo group nitrogen. Docking studies were performed with some of the key enzymes, such as ribonucleotide reductase, thymidylate synthase, thymidylate phosphorylase and topoisomerase II, which take part in the synthesis of raw materials for DNA and its replication [28] . The docking studies indicated that the azo group nitrogen atoms and formyl, carbonyl and ester oxygen atoms in the ligand moiety play an important role. They exhibit hydrogen bonding interactions with the active site of amino acids of the aforementioned enzymes. The higher activity was attributed to the presence of the azo group nitrogen atoms in the molecules of triphenyltin (IV) complexes [27] . As a continuation of our previous work in this area, we report some new triphenyltin(IV) complexes, Ph 3 SnL
H (1-4), of related systems where the ligand skeletal framework has been modified (Scheme 1) in an attempt to improve the dissolution properties and thereby influence cytotoxicity. The carboxylate ligands selected herein have variations in the position of the carboxylate functionality in the diazo part and also have variations of the nuclear substituents in the coupling moieties of the molecule. The newly synthesized complexes (1) (2) (3) (4) were characterized by spectroscopic ( [29] were tested across a panel of human tumor cell lines consisting of A498 (renal cancer), EVSA-T (mammary cancer), H226 (non-small-cell lung cancer), IGROV (ovarian cancer), M19 MEL (melanoma), MCF-7 (mammary cancer) and WIDR (colon cancer) and the results were compared with analogous Ph 3 SnL 6 H (6), Ph 3 SnL 7 H (7) [27] and related tributyltin(IV) complexes (8-11) (see Scheme 1 for complex description).
Experimental

Materials
Ph 3 SnOH was prepared from Ph 3 SnCl (Fluka) by following the literature method [30] . (Ph 3 Sn) 2 O (Fluka), 2-hydroxybenzaldehyde (Sisco), 2-methylphenol, 4-methylphenol, 4-tert-butylphenol (Merck), anthranilic acid (Spectrochem), and 4-aminobenzoic acid (Hi Media) were used without further purification. The solvents used in the reactions were of AR grade and were dried using standard procedures. Toluene was distilled from sodium benzophenone ketyl.
Physical measurements
Carbon, hydrogen and nitrogen analyses were performed with a Perkin Elmer 2400 series II instrument. IR spectra in the range 4000-400 cm 
Synthesis of ligands and complexes
HH′) [31, 33] , and complex 5 [29] were prepared by the methods described in our earlier reports and purities were established from melting point, elemental analysis and 1 H NMR spectroscopy. 2 O (0.42 g, 0.59 mmol) in anhydrous toluene (40 ml) in a 100 ml flask equipped with a Dean-Stark moisture trap and watercooled condenser. The reaction mixture was refluxed for 9 h and filtered while hot. The filtrate was collected and the volatiles removed using a rotary evaporator. The residue was dried in vacuo, washed with hexane (3 × 5 ml), extracted into benzene and filtered. The filtrate was concentrated and petroleum ether added to precipitate the crude product, which was collected by filtration and dried in vacuo (m.p.: 152-154°C). Recrystallization from benzene gave maroon crystals of the desired product in 55% (0.40 g) yield. M. 17 mmol). The reaction mixture was refluxed for 6 h and the water formed during the reaction being removed azeotropically using a Dean-Stark apparatus. The reaction mixture was filtered while hot and the filtrate was evaporated to dryness using a rotary evaporator. The dried mass was washed thoroughly with hexane, extracted into anhydrous benzene and filtered. The filtrate was concentrated slowly on a hot plate, cooled to room temperature and solid precipitated with hexane. The crude product was collected by filtration, washed several times with hot hexane and recrystallized using benzene to afford yellow crystalline material in 45% (0. 
Experimental protocol and cytotoxicity tests
The in vitro cytotoxicity testing of triphenyltin(IV) complexes 1-5 was performed using the SRB test for estimation of cell viability. Experimental protocols for 6 and 7 have been reported [27] and the cytotoxic results are included here for convenience of discussion. The cell lines WIDR colon carcinoma, M19 MEL melanoma, A498 renal cell carcinoma, IGROV ovarian carcinoma and H226 non-small-cell lung cancer belong to the currently used anticancer screening panel of the NCI, USA [34] . The breast carcinoma MCF7 cell line is estrogen receptor (ER)+/progesterone receptor (PgR) + and the breast carcinoma cell line EVSA-T is (ER)-/(Pgr)-. Prior to the experiments, a mycoplasma test was carried out on all cell lines and found to be negative. All cell lines were maintained in a continuous logarithmic culture in RPMI 1640 medium with HEPES and phenol red. The medium was supplemented with 10% FCS, penicillin 100 μg/ml and streptomycin 100 μg/ml. The cells were mildly trypsinized for passage and for use in the experiments. RPMI and FCS were obtained from Life Technologies or from Gibco (Paisley, Scotland). SRB, DMSO, penicillin and streptomycin were obtained from Sigma (St. Louis MO, USA), TCA and acetic acid from Baker BV (Deventer, NL) and PBS from NPBI BV (Emmer-Compascuum, NL).
The test complexes 1-5 and reference compounds were dissolved to a concentration of 250,000 ng/ml in full medium, by dilution of a stock solution which contained 5 mg of complexes 1-5/ml in DMSO. (Note: Complex 1 did not dissolve well in DMSO and hence needed stirring at 37°C and then at 50°C, but it still did not dissolve completely and therefore a suspension of the test complex 1 in DMSO was used to make the dilutions in medium). The compounds were subsequently diluted to a final concentration of 250,000 ng/ml in full medium. Cytotoxicity was estimated by the microculture sulforhodamine B (SRB) test [35] .
The experiment was started on day 0. On day 0, 1500-2000 cells per well were seeded into 96-wells flat-bottomed micro-titer plates (Cellstar, Greiner Bio-one). The plates were pre-incubated overnight at 37°C, 5% CO 2 to allow the cells to adhere to the bottom. On day 2, a three-fold dilution sequence of ten steps was made in full medium, starting with the 250,000 ng/ml stock solution. Every dilution was used in quadruplicate by adding 50 μl to a column of four wells. This procedure results in the highest concentration of 62,500 ng/ml being present in column 12. Column 2 was used for the blank.
Medium was added to column 1 to diminish interfering evaporation. On day 7, the incubation was terminated. Subsequently, the cells were fixed with 10% trichloroacetic acid in PBS and placed at 4°C for an hour. After three washings with tap water, the cells were stained for at least 15 min with 0.4% SRB dissolved in 1% acetic acid. After staining, the cells were washed with 1% acetic acid to remove the unbound stain. The plates were air-dried and the bound stain was dissolved in 150 μl 10 mM Tris-base. The absorbance was measured at 540 nm using an automated microplate reader (Labsystems Multiskan MS). The data were used for construction of concentrationresponse curves and determination of the ID 50 values by use of Deltasoft 3 software. ID 50 is the dose in ng/ml that causes 50% inhibition of the tumor cells.
The variability of the in vitro cytotoxicity test depends on the cell lines used and the serum applied. With the same batch of cell lines and the same batch of serum the inter-experimental CV (coefficient of variation) is 1-11% depending on the cell line and the intraexperimental CV is 2-4%. These values may be higher in the other batches of cell lines and/or serum.
Quantitative structure-activity relationship (QSAR) methods
QSAR models were developed by the C-QSAR program [36] using multi-regression analyses (MRA). This program avoids the collinearity problem by auto-selection of descriptors based on permutation and correlation matrices among the descriptors. Details about this program and its use in the development of QSAR models can be seen in previous publications [37, 38] . The in vitro cytotoxicity data (ID 50 ; ng/ml) of organotin(IV) compounds 1-20 along with some standard drug molecules against a panel of seven human tumor cell lines are summarized in Table 5 . In QSAR analysis, we often like to convert the concentration ID 50 of the compound into an activity parameter "A" using the following equation A = − log ID 50 = log 1/ID 50 in molar concentration. This transformation represents that the more potent compound always has a higher "activity" and vice versa [39, 40] . This is the reason the in vitro cytotoxicity data (ID 50 ; ng/ml) (see Table 5 ) was converted into an activity parameter log 1/ID 50 (mol l -1 ) using the following equation: log 1/ID 50 (mol l -1 ) = 6 -log [ID 50 (ng/ml)/MW] and then the QSAR models were developed. Clog P is the calculated partition coefficient of a compound in octanol/water system and is a measure of its hydrophobicity, while CMR is the calculated molar refractivity for the whole molecule [36, 41] .
In all QSAR models, n is the number of data points, r 2 is the square of the correlation coefficient, q 2 is the cross-validated r 2 , s is the standard deviation, Q is the quality factor, and F is the Fischer ratio. The cross-validated r 2 (q 2 ) is obtained by using the leave-one-out (LOO)
procedure [42] . In each QSAR model, the value of F in parenthesis refers to their literature value at 95% level [43] . The modeling was taken to be optimal when Q reached a maximum together with F, even if slightly non-optimal F values have normally been accepted. A compound was assigned as an outlier on the basis of deviation between observed and predicted activities from the respective QSAR model H (4) suitable for single crystal X-ray structure determination were obtained from slow evaporation of benzene, acetone and chloroform solutions of the complexes, respectively. Intensity data were collected with graphite-monochromated MoKα radiation (λ = 0.71073 Å) on a Bruker D8 goniometer equipped with a SMART APEX CCD detector. Frames were collected in ω-scan mode and integrated with the help of the program SAINT [45] . Crystal data, data collection parameters and convergence results are listed in Table 2 . Absorption corrections based on a multi-scan approach [46] were applied to the data sets before averaging over symmetry-related reflections. The structures were solved by direct methods with the help of the program SHELXS-97 [47] and refined on reflection intensities F 2 using SHELXL-97 [47] . In the final least-squares refinements, nonhydrogen atoms were refined with anisotropic displacement parameters and hydrogen atoms were placed in idealized positions and included as riding on the corresponding atoms.
The quality of the intensity data sets varied considerably: only room temperature data were available for 1. 18 distance restraints and 656 rigid-bond restraints were used during refinement, and reliability factors were rather high. In the case of 3, low temperature (130 (2) K) data were available; in each of the two symmetrically independent molecules one of the phenyl rings attached to the metal was disordered over two orientations; a total of 144 restraints were employed in the final structure model, and partially occupied atom Table 2 Crystal data, data collection parameters and convergence results for complexes 1, 3 and 4. Sn) coupling constants [29, 48, 49] . In CDCl 3 , the triphenyltin(IV) complexes (1-4) exhibit a single sharp 119 Sn resonance at around −105 ppm, suggesting that the Sn-atom in the complexes are isostructural in solution where the tin atom is four-coordinate [27, 29, 49, 50] . ) (see Γ av in Table 1 ), which is consistent with the occurrence of only one absorbing species. The experimental Mössbauer parameters are reported in Table 1 , together with calculated Δ according to the point-charge model formalism applied to the idealized tetrahedral structure [51] [52] [53] [54] [55] [56] . The difference between experimental and calculated values does not exceed the limit of tolerance of the method (± 0.4 mm s -1 ) [55] , and thus the experimental |Δ exp | data can be explained satisfactorily by assuming a slightly distorted tetrahedral geometry [56] . As a consequence, taking into account the proposed tetracoordination of tin(IV) and using the Parish equation, the calculated C-Sn-OCO angles for the complexes 1-4 lie in the range 107.6-109.3° [56] (see Table 1 ).
Crystal structures
The crystal structures of three of the triphenyltin complexes (1, 3 and 4) have been determined. Crystal data, data collection parameters and refinement results are given in Table 2 . All three complexes crystallize in the triclinic space group P 1. The crystal structures of 1 and 3 feature two independent molecules in the asymmetric unit. Views of the molecules of 1, 3 and 4 are shown in Figs. 1-3 . With respect to the metal coordination, the structures conform to the same motif. Selected geometric parameters are given in Table 3 . As indicated by the 119 Sn Mössbauer spectroscopy, the molecules are monomeric in the solid state. The tin atom is four coordinate with a distorted tetrahedral geometry defined by a C 3 O donor set. The tetrahedral angles for the five molecules range between 93.50 (8) (Table 3 ). The secondary Sn-O(2) interaction causes a slight distortion of the tetrahedral primary coordination sphere but should not be regarded as a strong coordinative bond: The bond angles around the Sn atom in 1, 3 and 4 are more consistent with a tetrahedral environment than with a trigonal bipyramidal or square-pyramidal five-coordinate arrangement, and the (Table 4) . In all three compounds, the hydroxy oxygen atom O(3) acts as the donor and N(1) as the acceptor of an intramolecular hydrogen bond with graph set symbol S(6) [62] . As a result of the 1, 2 substitution in the aromatic ring C(2)-C (7), molecules of 4 adopt a more compact conformation than those in 1 and 3. The packing diagrams for 1, 3 and 4 can be viewed in Figs. S1-S3.
Cytotoxicity studies
Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]
benzoates, e.g. 6-7, are an important class of compounds as they have shown both effective docking results, particularly the hydrogen bonding interactions through the azo group nitrogen atoms, formyl, carbonyl and ester oxygen atoms with various key enzymes, and cytotoxic potential [27] . (12) (13) (14) (15) (16) (17) [25, 26] , terebate, steroidcarboxylate and benzocrowncarboxylate (18) (19) (20) [23] , which have shown promising activity. When looking into the antitumor test results of triorganotin(IV) derivatives, the question of hydrolysis yielding e.g. triphenyltin hydroxide as an active species may arise. The potent and similar in vitro activity of triphenyltin(IV) benzoates suggested triphenyltin hydroxide as the common intermediate responsible for cytotoxicity [63] and this hypothesis was also proposed for a series of dioxastannolanes. Later, this proposal was abandoned because of the observed resistance in the cell lines which was not seen with triphenyltin hydroxide [64] . Organotin(IV) carboxylates proved to be stable at least for days in water [65] . In our test system, either ethanol or DMSO solution of the organotin(IV) compound is diluted with test medium. In case of compounds insoluble in aqueous media, the test procedure is discontinued because of improper outcomes. Consequently, no reliable test results could be obtained for triaryllead hydroxides and also for some stannoxanes. This was also confirmed by others e.g. for triphenyltin hydroxide [66, 67] . Some poorly water soluble stannoxanes were tested and showed high cytotoxicity [68] [69] [70] [71] [72] . Several series of organotin(IV) compounds containing diazenyl group were studied for some years and no signs of hydrolysis were observed during spectroscopic measurements and in vitro testing protocols. These compounds invariably displayed different ID 50 values and different reactivities towards enzymes. The organotin(IV) compounds studied may form intermediates in test medium containing tumor cells as with many cytotoxic compounds, but there was no sign of a common intermediate.
The triphenyltin(IV) complexes of the present investigation deserve specific mention. In complexes (4-7), the triphenyltin(IV) carboxylate is o-positioned in the diazo-forming moiety, while in compounds 1-3 it is p-positioned (see Scheme 1) . The cytotoxicity data (ID 50 ) for the test complexes (1-3) are of the same order of magnitude and the change of ligand substitution does not influence the cytotoxic activity significantly. The results of 1-3 are also comparable to that of its o-analogs, i.e. 4-7, except 5. Pair wise comparison of the Table 6) . Table 3 Selected geometric parameters (Å,°) a for the triphenyltin(IV) complexes 1, 3 and 4.
3 4
a Values in square brackets with the atom label extension 'a' refer to the second independent molecule in the asymmetric unit. complexes, wherein the ligand nuclear substituents are held constant, was also necessary to judge the influence of the p-and o-derivatives. For pair 1 and 5, the p-derivative 1 is found to be more active, while for pairs 3 and 4, and 2 and 6, both p-and o-derivatives displayed comparable activity. Upon closer inspection of the ID 50 values of 1 and 5, one can see that 1 is two folds more cytotoxic than 5 for the cell line MCF-7 and similar observations were noted for pairs 3 and 4, and 2 and 6. As noted, 5 is an exception; its lower cytotoxicity might be the result of internal co-ordination of OH with Sn. This can make the Sn less attractive for co-ordination with DNA or sugar moieties. The larger t-Bu group might impede the internal co-ordination. In a manner similar to 4-7, a comparison is possible for Ph 3 SnLH (2-4) and Bu 3 SnLH (8-11) since each set of complexes contains a common ligand frame work. Triphenyltin(IV) complexes 2-4 were found to be more active than corresponding tributyltin(IV) complexes 8-11. In general, the cytotoxic results of complexes 1-3 are undoubtedly far superior to CDDP, 5-FU and ETO, and related tributyltin(IV) complexes 8-11. Triphenyltin(IV) complexes 1-3 deserve merit over their o-analogs (4-6) for better activity, particularly against MCF-7 cell line. On the other hand, although the ID 50 values for the test complexes (1-4) of the present investigation are also similar to that of the triphenyltin(IV) complexes of Schiff bases derived from L-leucine and phenylalanine [25, 26] , their advantage lies in the stability. It should be mentioned here that the triphenyltin(IV) 2/4-
are stable for a significantly longer period in both the solid-state and in solution than triphenyltin (IV) complexes containing amino acetate skeletons [25, 26] . Thus, the cytotoxicity data of complexes 1-3, together with better solubility, is suggestive of promising candidates for further in vitro and in vivo studies after appropriate modifications. The cytotoxicity data of complexes 1-3 further indicate that structural variation of the L-R skeletons does not influence the activity. However, attempts were made to provide additional precise information from the quantitative structure-activity relationship (see below).
QSAR studies
From the cytotoxicity data [log 1/ID 50 (mol l
)] of organotin(IV) compounds 1-11 in Table 6 , the following QSAR models 1-7 were developed:QSAR for the cytotoxicity of compounds 1-11 against A498 human tumor cell line (Table 6) QSAR for the cytotoxicity of compounds 1-11 against H226 human tumor cell line (Table 6) 
QSAR for the cytotoxicity of compounds 1-11 against MCF-7 human tumor cell line (Table 6) log1=ID 50 
outliers: compounds 4-7 Table 5 In vitro ID 50 values (ng/ml) of test complexes 1-5, reported organotin(IV) complexes (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) and standard drugs using cell viability tests in seven human tumor cell lines QSAR for the cytotoxicity of compounds 1-11 against WIDR human tumor cell line (Table 6) QSAR models 1-6 are well defined by two descriptors; Clog P and CMR (Fig. 4 of QSAR 5 represents the best example). But for the QSAR 7, the cytotoxic activity is well correlated with only the CMR term and there is no role of hydrophobic parameter. On comparing the statistical contribution of Clog P and CMR descriptors, it has been found that CMR is a more important parameter than that of Clog P. CMR explains 65%, 77%, 63%, 54%, 72%, 72%, and 90%, respectively, of the variance in the data of QSAR models 1-7, while Clog P accounts for only 18%, 19%, 21%, 27%, 17%, and 27%, respectively, of the variance in the data of QSAR models 1-6. Thus CMR (steric/polarizability factor) plays a major role for the cytotoxicity of organotin(IV) compounds 1-11 against a panel of seven human tumor cell lines studied.
Compounds were deemed to be outliers in QSARs (Eqs. (2), (6), and (7)) on the basis of deviations in their activities (obsdpred > 2 × s). To assess the effects of excluding outlier(s), QSAR models were examined thoroughly before and after the removal of a compound. Although QSAR 6 is a very good model with respect to their statistics, we could not consider it as a predictive model. This is because the QSAR 6 was developed for a very small data set using two descriptors and also after removing four outliers. A large number of outliers for this QSAR model may suggest the combination of used descriptors (Clog P and CMR) is not sufficient enough and may need the additional descriptor(s), but the additional descriptor(s) cannot be considered due to the very small data set. Lastly, we kept this equation only for the comparison point of view.
The presence of Clog P term with negative coefficient in QSARs 1-6 suggests that the cytotoxicity of compounds 1-11 decreases with increasing hydrophobicity against six cancer cell lines (e.g. A498, EVSA-T, H226, IGROV, M19 MEL, and MCF-7). On the contrary, the cytotoxicity of these compounds increases with increasing their steric/polarizability (CMR) against all the seven cancer cell lines as evident by the positive coefficient of the CMR term. Although there are high statistics associated with QSARs 1-6 (r 2 = 0.807-0.983), the C log P of compounds 1-11 with high values (6.37-8.81) are not great enough to establish the upper limit of the activity, these compounds may have higher C log P values than that of the optimum. It suggests that QSARs 1-6 may represent only the second half of the parabolic/bilinear model in terms of C log P, which may be the cause for the presence of negative C log P term in QSARs 1-6. Thus, more compounds with lower C log P (C log P b 6.37) values will be needed to establish the upper C log P limit either for the development of a parabolic or bilinear QSAR model. On comparison among QSAR models 1-7, one can suggest that the mechanism for the cytotoxic activity of compounds 1-11 against A498, EVSA-T, H226, IGROV, M19 MEL, and MCF-7 cancer cell lines is almost the same and depends directly on the hydrophobic and molar refractivity parameters of the compound. It must be noted here that QSARs 1 and 3-5 explain 82.3-88.2% of the variance in the data sets without any outlier, but QSARs 2 and 6 explain 95.9% and 98.3% of the variance in the data sets with the help of 2 and 4 outliers, respectively. Thus QSARs 2 and 6 are not exactly the same to that of QSARs 1 and 3-5. Now, it can be concluded that the mechanism for the cytotoxic activity of compounds 1-11 against A498, H226, IGROV, and M19 MEL cancer cell lines is almost the same, but somewhat different from that of against EVSA-T and MCF-7 cancer cell lines. These cancer cell lines may have some different mechanism in addition to the common one. On the other hand, QSAR 7 explains 90.3% of the variance in the data set using only one CMR descriptor and one outlier. There is no room to accommodate the hydrophobic term in this QSAR model, which suggests that the cytotoxic activity of compounds 1-11 against WIDR cancer cell line may have some different mechanism in comparison to that of the other six cancer cell lines such as A498, EVSA-T, H226, IGROV, M19 MEL, and MCF-7. The similar mechanism for the cytotoxic activity of compounds 1-11 against A498, H226, IGROV, and M19 MEL cancer cell lines can also be demonstrated by very high mutual correlations (r 2 = 0.948-0.996) in activity-activity relationships i.e. the direct comparison among the cytotoxic activity of compounds 1-11 against A498, H226, IGROV, and M19 MEL cancer cell lines as shown in Table 7 and Figs. 5, S4-S8.
Validation of QSAR models
Two steps, statistical diagnostics and internal validation, were used to validate QSAR models 1-7. In statistical diagnostics, QSARs 1-7 were filtered through the following conditions:
95% level (vi) high Q value, and (vii) low s value [43, [73] [74] [75] [76] [77] [78] . On the other hand, the internal validation was carried out by using crossvalidation (q 2 > 0.5) [74, 77] . Since there is not sufficient difference in activities of compounds, there is probability of a chance correlation in the QSAR models. To examine this problem, we performed a Yrandomization test. According to this test, if a strong correlation remains between the selected descriptor(s) and the randomly permuted response, the significance of the proposed QSAR is suspect [44, 73, 77, 78] . In the Y-randomization test, the poor values of r 2 and q 2 in Table 8 ensure the robustness of the QSAR models 1-7 and also the lack of over fitting. Due to the small data sets, the external validation test was not considered. Although QSAR models 1-7 have been passed through all the necessary validation tests, we did not consider these models as the predictive QSAR models due to the presence of low activity range (b1 log unit) in the data sets. To construct the predictive QSAR models, we need to synthesize additional organotin(IV) compounds similar to compounds 1-11 with lower C log P (C log P b 6.37) and higher/similar CMR values. It is interesting to note that there is no mutual correlation between C log P and CMR of compounds 1-11 (C log P vs CMR; r = 0.025), providing us enough space to manipulate the structure of organotin(IV) compounds 1-11 with respect to their varying C log P and CMR in order to obtain the compound with desired activity.
Conclusions and outlook
We reported here the syntheses, characterization and cytotoxic activities of some new triphenyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl] benzoates (1) (2) (3) (4) . Our studies have demonstrated the potential of developing compounds 1-4 as effective cytotoxic agents on all the cell lines studied, particularly MCF-7 with an ID 50 range of 41-53 ng/ml in vitro. Complexes 1-4 appear to display similar cytotoxicity, irrespective of their nuclear substituents in the coupling moiety. From QSAR models 1-7 it can be suggested that the cytotoxicity of compounds 1-11 against the four different cancer cell lines (A498, H226, IGROV, and M19 MEL) are due to a very similar mechanism, but the same is not true against the EVSA-T, MCF-7, and WIDR cancer cell lines. These three cancer cell lines may have some different mechanism in addition to the common one. The triphenyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates (1-4) may therefore be explored further by in vivo testing in animal models to develop them as anticancer chemotherapeutics. Further work in this area is underway.
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Table 7
Statistical data for the correlations among the cytotoxic activities of compounds 1-11 (n = 11) against four cancer cell lines e.g. A498, H226, IGROV, and M19 MEL. Table 7) . 
